- Home
- DOUG vs SOPH Comparison
DOUG vs SOPH Comparison
Compare DOUG & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOUG
- SOPH
- Stock Information
- Founded
- DOUG 1911
- SOPH 2011
- Country
- DOUG United States
- SOPH Switzerland
- Employees
- DOUG N/A
- SOPH N/A
- Industry
- DOUG Building operators
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DOUG Real Estate
- SOPH Health Care
- Exchange
- DOUG Nasdaq
- SOPH Nasdaq
- Market Cap
- DOUG 161.5M
- SOPH 193.8M
- IPO Year
- DOUG N/A
- SOPH 2021
- Fundamental
- Price
- DOUG $2.31
- SOPH $2.99
- Analyst Decision
- DOUG
- SOPH Buy
- Analyst Count
- DOUG 0
- SOPH 1
- Target Price
- DOUG N/A
- SOPH $7.00
- AVG Volume (30 Days)
- DOUG 1.0M
- SOPH 171.1K
- Earning Date
- DOUG 08-06-2025
- SOPH 08-05-2025
- Dividend Yield
- DOUG N/A
- SOPH N/A
- EPS Growth
- DOUG N/A
- SOPH N/A
- EPS
- DOUG N/A
- SOPH N/A
- Revenue
- DOUG $1,048,791,000.00
- SOPH $67,173,000.00
- Revenue This Year
- DOUG $17.61
- SOPH $16.07
- Revenue Next Year
- DOUG N/A
- SOPH $22.94
- P/E Ratio
- DOUG N/A
- SOPH N/A
- Revenue Growth
- DOUG 11.36
- SOPH 4.66
- 52 Week Low
- DOUG $1.03
- SOPH $2.58
- 52 Week High
- DOUG $3.20
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- DOUG 45.13
- SOPH 52.64
- Support Level
- DOUG $2.27
- SOPH $2.99
- Resistance Level
- DOUG $2.46
- SOPH $3.40
- Average True Range (ATR)
- DOUG 0.13
- SOPH 0.25
- MACD
- DOUG -0.06
- SOPH 0.01
- Stochastic Oscillator
- DOUG 15.80
- SOPH 62.65
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees. It derives revenue from Real Estate Brokerage segment.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.